Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Major shareholder
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
ICPO Foundation partners with the International Atomic Energy Agency (IAEA)
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SEGRO plc - Ordinary Shares
-
Fluke Reliability’s EAM solution eMaint positioned as a Leader in Green Quadrant for Enterprise Asset Management
-
Cyber A.I. Group and A1 Advisory Announce Strategic Partnership
-
With Only 1 in 3 Workers in Europe Excited to Use AI, Trust Boosts Confidence at 100 Best in Europe
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Verkkokauppa.com to publish January-September 2024 Interim Report on 24 October 2024
-
Sanoma will publish its Q3 2024 Interim Report on 31 October
-
Share Buyback Transaction Details October 3 – October 9, 2024
-
Solvay completes its largest GHG emissions reduction project yet, transforming U.S. Green River operations
-
Form 8.5 (EPT/RI) Eckoh Plc
-
WOO Innovation Hub and SphereX Partner to Elevate Meme-Driven Decentralized Trading
-
HSBC Continental Europe: Post Stabilisation Notice
-
MitoRx Therapeutics Announces Publication Showing Mitochondrial Sulfide Donor AP39 Significantly Alleviates Obesity
-
Bybit Reports Milestones as bbSOL Concludes First Month on Solana Blockchain
-
The sales of VILVI GROUP September 2024
-
Fashion Brand Sincethen Hosts Brand Day from October 8 to 14
-
Corrections to Final Terms - Nykredit Realkredit A/S
-
Syensqo - Participation notification by BlackRock Finance Inc.
-
Replacement in bonds for new lending - Nykredit Realkredit A/S
-
AB Science: Revenues for the first half of 2024 and update on AB Science’s activities
-
Cornish Metals Appoints Endeavour Financial as Financial Adviser to Arrange Project Financing for South Crofty Tin Project
-
Completion of divestment of UK Municipal operations
-
Avacta to Unveil Pipeline Expansion and Novel, Next-Generational Targeted Cancer Therapy Programs at 2024 EORTC-NCI-AACR Symposium
-
Corporate Update
-
Pharming Group to report third quarter 2024 financial results on October 24
-
Aenitis Secures Strategic Funding to Redefine Bioproduction with Sole-In-Class Acoustofluidic Technology
-
KBC Group: Publication of transparency notification(s) received by KBC Group NV
-
New Zealand Banking Association choose obconnect to deliver Confirmation of Payee ecosystem
-
Transaction in Own Shares
-
Sampo plc’s share buybacks 9 October 2024
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers fourth milestone payment for this region to Basilea this year
-
Start of Day Message
-
Nokia to publish third-quarter and January-September 2024 interim report on 17 October 2024
-
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation
-
Fagron reports outstanding third quarter 2024 performance with 12.1% revenue growth and reaffirms full-year outlook
-
Valneva Hosts Investor Day in New York City
-
Roche obtains CE certification for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY
-
The net asset value of EfTEN Real Estate Fund AS shares as of 30.09.2024
-
Ascom has been awarded a major contract by the Canton of Zurich to install Ascom’s new Security Support System in nine penal institutions
-
OKX Announces Pre-Market Futures for Scroll, Launches 'Borrow in Spot' Feature
-
OKX Announces Pre-Market Futures for Scroll, Launches 'Borrow in Spot' Feature
-
Automakers quickly improve seat belt reminders in response to IIHS ratings
-
Nurturing Nature: Garden Beau's Commitment to Sustainable Solutions
-
Nurturing Nature: Garden Beau's Commitment to Sustainable Solutions
-
Pilgrim’s Pride Corporation to Host Third Quarter Earnings Call on October 31, 2024
